<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We report a 71-year-old man who presented with severe subcutaneous and later psoas muscle haemorrhage in the presence of a raised white cell count and <z:hpo ids='HP_0001433'>hepatosplenomegaly</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>A circulating factor VIII (FVIII) inhibitor was detected and bone marrow <z:mp ids='MP_0000002'>morphology</z:mp> confirmed the presence of a myeloproliferative/<z:mpath ids='MPATH_341'>myelodysplastic disorder</z:mpath> </plain></SENT>
<SENT sid="2" pm="."><plain>Initial treatment with high dose FVIII followed by recombinant factor VIIa was unsuccessful </plain></SENT>
<SENT sid="3" pm="."><plain>Haemorrhage was controlled by the administration of activated prothrombin complex concentrate (FEIBA; Baxter healthcare, CA, USA) in combination with <z:chebi fb="2" ids="8378">prednisolone</z:chebi>, <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi> and i.v. immunoglobulin </plain></SENT>
<SENT sid="4" pm="."><plain>The inhibitor became undetectable 14 weeks after presentation </plain></SENT>
<SENT sid="5" pm="."><plain>The white cell count responded initially to <z:chebi fb="0" ids="44423">hydroxyurea</z:chebi> and later to <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi> </plain></SENT>
<SENT sid="6" pm="."><plain>There have been only two previous reports of <z:e sem="disease" ids="C1096116" disease_type="Disease or Syndrome" abbrv="">acquired haemophilia</z:e> A in association with <z:mpath ids='MPATH_341'>myelodysplastic disorders</z:mpath> and no previous report of an association with a <z:hpo ids='HP_0005547'>myeloproliferative disorder</z:hpo> </plain></SENT>
</text></document>